Navigation Links
Ernst & Young LLP's Todd Skrinar Named One of the 100 Most Inspiring People in Life Sciences
Date:8/6/2014

NEW YORK, Aug. 6, 2014 /PRNewswire/ -- Todd Skrinar, principal, Ernst & Young LLP, and West Coast leader of the Advisory Life Sciences practice, has been recognized by PharmaVOICE as one of the "100 Most Inspiring People in the Life Sciences Industry" for 2014. Skrinar was selected for his positive impact on the industry, his inspirational leadership and his ability to innovate and turn problems into opportunities.

"We are thrilled that Todd's leadership, talent and contributions to the industry are being recognized," said Kim Ramko, principal, Ernst & Young LLP, and EY Global and Americas Life Sciences sector leader. "In these transformative times, our clients know they can count on Todd to anticipate industry changes before they happen and lead them through complex and challenging situations. It is only fitting that he be honored for his dedication to his clients and his passion for the life sciences."

Nominations for the PharmaVOICE 100 are submitted by industry peers. Editors then select those who demonstrate exceptional leadership and have had a positive impact on the life sciences industry.

Skrinar has more than 23 years of experience creating competitive advantage through technology. He is known for championing the potential of big data and analytics to improve business operations. As part of his selection, PharmaVOICE noted Todd's reputation as a trusted advisor to clients, a leader among his peers and a mentor to others.

"I'm honored and humbled to be recognized along with so many other deserving life sciences professionals," said Skrinar. "I am lucky to have an opportunity to work with outstanding colleagues and exceptional clients and I'm excited to be a part of the technological revolution that is leading to an industry transformation."

Before joining EY, Todd led the West Region of the Life Sciences practice of IBM Global Business Services and was previously was the lead of the Health and Life Sciences consulting practice at Unisys. 

Skrinar earned a B.S. in Business Administration from Boston University and a M.B.A. from Emory University.  He is based in San Francisco.

The full list of PharmaVOICE 100 recipients appears in the July/August 2014 issue of PharmaVOICE magazine and is available at www.pharmavoice.com.

About EY's Advisory Services
Improving business performance while managing risk is an increasingly complex business challenge. Whether your focus is on broad business transformation or more specifically on achieving growth, optimizing or protecting your business having the right advisors on your side can make all the difference. Our 30,000 advisory professionals form one of the broadest global advisory networks of any professional organization, delivering seasoned multidisciplinary teams that work with our clients to deliver a powerful and exceptional client service. We use proven, integrated methodologies to help you solve your most challenging business problems, deliver a strong performance in complex market conditions and build sustainable stakeholder confidence for the longer term. We understand that you need services that are adapted to your industry issues, so we bring our broad sector experience and deep subject matter knowledge to bear in a proactive and objective way. Above all, we are committed to measuring the gains and identifying where your strategy and change initiatives are delivering the value your business needs.

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

This release has been issued by Ernst & Young LLP, an EY member firm serving clients in the US.

Logo - http://photos.prnewswire.com/prnh/20130701/NY40565LOGO-b


'/>"/>
SOURCE EY
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year® 2012 Award in New Jersey
2. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
3. Masimo CEO Joe Kiani Named Ernst & Young Entrepreneur of the Year
4. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
5. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
6. MedAvante Honored By Ernst & Young LLP and Red Herring
7. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
8. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
9. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
10. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
11. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... -- A new study by a pair of Geisinger Health ... to treat chronic pain is not only ineffective, it ... including death. Palliative care physicians Mellar ... M.D., authored the study which provides a review of ... was published in the December 2016 edition of Current ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Medicine will have the unique opportunity to get hands-on experience in an ... school students an immersive experience to gain invaluable, real-life medical skills that are ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... drug in their bodies, a researcher at the Icahn School of Medicine at ... , The study found that when young children are exposed to secondhand marijuana ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... a women growing up with a schizophrenic mother in a unique, personal perspective ... who specializes in treating trauma and addictive disorders at her private psychotherapy practice. ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to ... analyzed data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical ... the need to operate in a GLP (Good Laboratory Practice) fashion. , With features ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein ... according to a study appearing online in the journal Radiology. , Heart disease and ... increase significantly due to the rapidly aging population. Damage to both organs often occurs ...
Breaking Medicine News(10 mins):